Memorial Day! 45% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s
AI Analysis AI Analysis of CASI
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Evaluation of CASI Pharmaceuticals stock downgraded after the last trading session
(Updated on May 22, 2025)

Sell candidate since May 22, 2025

The CASI Pharmaceuticals stock price fell by -1.57% on the last day (Thursday, 22nd May 2025) from $1.92 to $1.89. During the last trading day the stock fluctuated 4.81% from a day low at $1.87 to a day high of $1.96. The price has fallen in 6 of the last 10 days and is down by -2.46% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 10 thousand shares were bought and sold for approximately $19.45 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.12% during the next 3 months and, with a 90% probability hold a price between $1.29 and $1.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

CASI Signals & Forecast

There are mixed signals in the stock today. The CASI Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.89 and $1.95. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, May 07, 2025, and so far it has risen 10.49%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for CASI Pharmaceuticals stock

CASI Pharmaceuticals finds support from accumulated volume at $1.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0900 between high and low, or 4.81%. For the last week the stock has had daily average volatility of 6.58%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CASI) For The Upcoming Trading Day Of Friday 23rd

For the upcoming trading day on Friday, 23rd we expect CASI Pharmaceuticals to open at $1.91, and during the day (based on 14 day Average True Range), to move between $1.76 and $2.02, which gives a possible trading interval of +/-$0.135 (+/-7.12%) up or down from last closing price. If CASI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 14.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.87 (1.05%) than the resistance at $1.92 (1.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CASI Pharmaceuticals stock A Buy?

CASI Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.617 Sell Candidate Downgraded

Want to trade but not sure how? Our step-by-step guide can help. Skip the guide? Open account with our trusted broker

Predicted Fair Opening Price

Predicted fair opening price on May 23, 2025 - $1.91 ( 0.89%).

CASI Performance

Trading levels for CASI

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.00 5.65%
R2 1.96 3.83%
R1 1.94 2.70%
Price 1.89
S1 1.87 -0.93%
S2 1.85 -2.06%
S3 1.82 -3.88%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.11 11.65%
R2 2.10 10.98%
R1 1.92 1.59%
Price 1.89
S1 1.87 -1.05%
S2 1.81 -4.23%
S3 1.80 -4.76%

FAQ

What is the symbol for CASI Pharmaceuticals Stock and on which exchange is it traded?
The symbol for CASI Pharmaceuticals is CASI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CASI Pharmaceuticals Stock?
CASI Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy CASI Pharmaceuticals Stock?
CASI Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CASI Pharmaceuticals Stock.

What's the current price of CASI Pharmaceuticals Stock?
As of the end of day on the May 22, 2025, the price of an CASI Pharmaceuticals (CASI) share was $1.89.

What is the 52-week high and low for CASI Pharmaceuticals Stock?
The 52-week high for CASI Pharmaceuticals Stock is $7.67 and the 52-week low is $1.64.

What is the market capitalization of CASI Pharmaceuticals Stock?
As of the May 22, 2025, the market capitalization of CASI Pharmaceuticals is 29.746M.

When is the next earnings date for CASI Pharmaceuticals?
The upcoming earnings date for CASI Pharmaceuticals is Aug 15, 2025.
Click to get the best stock tips daily for free!
ABOUT CASI PHARMACEUTICALS
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve...
GOLDEN STAR
Ticker Change Signal Date
UAA
$5.84
11.64% May 09
IIPR
$54.61
1.70% May 09
HBM
$7.41
14.44% May 05
PODD
$257.01
24.90% May 02
GT
$9.14
21.77% Mar 21

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE